Gender-affirming care was rarely provided to minors from 2018 through 2022, according to new research out of Harvard ...
Only 926 adolescents with a gender-related diagnosis received puberty blockers from 2018 through 2022. During that time, ...
The use of gender-affirming medical care for trans teens was rare between 2018 to 2022, according to a new study published in ...
Share articleAs U.S. lawmakers debate issues around health care for transgender youth, it’s been difficult to determine the ...
Researchers say among those with private insurance, not one transgender person under 12 was prescribed gender-affirming hormones. “There’s not some massive wave of folks accessing care,” the report's ...
The study, published in JAMA Pediatrics on Monday, looked at private insurance claims representing over 5 million patients in ...
The findings, published in JAMA Pediatrics, suggest that fewer than 0.1% of all youth in the database received these medications. Only 926 adolescents were prescribed puberty blockers, and 1,927 ...
A new analysis of private insurance claims data finds less than 0.1% of youth accessed puberty blockers or hormones for ...
Fewer than one in 1,000 adolescents with commercial insurance received gender-affirming medication over a five-year period, ...
I am still enough of an institutionalist that it pains me to hear Supreme Court justices embarrassing ... that urged caution in the provision of puberty blockers to teens, Alito engaged in a ...